Karachi: Pakistan has finalized a significant trade agreement with the United States aimed at enhancing bilateral trade, expanding market access, and attracting foreign investment. The agreement, announced by AKD Securities Limited, is expected to fos...

Karachi: The State Bank of Pakistan (SBP) decided to maintain the policy rate at 11%, defying widespread market expectations for a cut. The Monetary Policy Committee (MPC) emphasized that the decision was critical to address the challenges posed by ri...

Karachi: Security Papers Limited (SPL) has announced its financial results for the fiscal year ending June 30, 2025, showcasing significant growth and profitability. The company reported a profit before tax of PKR 2,414 million, highlighting its stron...

Islamabad: The Board of Directors of Bank Alfalah Limited approved the bank's financial results for the half year ending June 30, 2025, announcing a profit after tax of PKR 15.27 billion. This equates to an earnings per share of PKR 9.68, a decrease f...

Karachi: Saudi Arabia's AlFursan Loyalty Program is gaining substantial traction among travelers, particularly those flying from Saudi Arabia. The program recently announced a new payment option called "Cash + Miles," allowing passengers to pay for a ...

Karachi: Habib Bank Limited (HBL) has reported robust financial results for the second quarter of the calendar year 2025, posting a net profit after tax of PKR 17.8 billion, which translates to earnings per share of PKR 12.12. This marks a 24% year-on...

Karachi: Bank Alfalah Limited (BAFL) disclosed its second-quarter financial results for the calendar year 2025, revealing a growth in net profit after tax (NPAT) to PkR8.2 billion, translating to earnings per share (EPS) of PkR5.22. The figures repres...

Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion-dollar global […]

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., […]